Clinical results with imatinib in chronic myeloid leukaemia
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference47 articles.
1. The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells;Deininger;Blood.,1997
2. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells;Druker;Nat Med.,1996
3. Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis;Gambacorti-Passerini;Blood Cells Mol. Dis.,1997
4. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukaemia;Druker;J. Clin. Invest.,2000
5. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukaemia;Druker;N Engl. J. Med.,2001
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacokinetics Interaction between Imatinib and Genistein in Rats;BioMed Research International;2015
2. Hematologic, liver enzymes and electrolytes changes in chronic myeloid leukemia after Imatinib medication;Indian Journal of Cancer;2015
3. Inhibitory effect of silybin on pharmacokinetics of imatinib in vivo and in vitro;Canadian Journal of Physiology and Pharmacology;2014-11
4. Synthesis and Bioevaluation of Novel Imatinib Base Derivatives via 1,1′-Carbonyldiimidazole Catalyst;Journal of Chemistry;2013
5. P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the Aurora-B Kinase Inhibitor barasertib-hQPA;BMC Cancer;2011-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3